(1R,2E,6E,10S)-3,7-dimethyl-10-propan-2-ylcyclodeca-2,6-dien-1-ol

Details

Top
Internal ID 69938c0e-f531-449d-b7d4-8bcee52a8753
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Germacrane sesquiterpenoids
IUPAC Name (1R,2E,6E,10S)-3,7-dimethyl-10-propan-2-ylcyclodeca-2,6-dien-1-ol
SMILES (Canonical) CC1=CCCC(=CC(C(CC1)C(C)C)O)C
SMILES (Isomeric) C/C/1=C\CC/C(=C/[C@@H]([C@@H](CC1)C(C)C)O)/C
InChI InChI=1S/C15H26O/c1-11(2)14-9-8-12(3)6-5-7-13(4)10-15(14)16/h6,10-11,14-16H,5,7-9H2,1-4H3/b12-6+,13-10+/t14-,15-/m0/s1
InChI Key PXMCURAOQSNMOZ-ZTJVYCIYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H26O
Molecular Weight 222.37 g/mol
Exact Mass 222.198365449 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 3.40
Atomic LogP (AlogP) 4.09
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1R,2E,6E,10S)-3,7-dimethyl-10-propan-2-ylcyclodeca-2,6-dien-1-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9949 99.49%
Caco-2 + 0.9197 91.97%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability + 0.5571 55.71%
Subcellular localzation Mitochondria 0.4740 47.40%
OATP2B1 inhibitior - 0.8522 85.22%
OATP1B1 inhibitior + 0.9655 96.55%
OATP1B3 inhibitior + 0.9318 93.18%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior - 0.8041 80.41%
P-glycoprotein inhibitior - 0.9286 92.86%
P-glycoprotein substrate - 0.9287 92.87%
CYP3A4 substrate - 0.5830 58.30%
CYP2C9 substrate - 0.8090 80.90%
CYP2D6 substrate - 0.7021 70.21%
CYP3A4 inhibition - 0.8096 80.96%
CYP2C9 inhibition - 0.7546 75.46%
CYP2C19 inhibition - 0.7735 77.35%
CYP2D6 inhibition - 0.9104 91.04%
CYP1A2 inhibition - 0.5741 57.41%
CYP2C8 inhibition - 0.9308 93.08%
CYP inhibitory promiscuity - 0.7251 72.51%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.8528 85.28%
Carcinogenicity (trinary) Non-required 0.6152 61.52%
Eye corrosion - 0.8378 83.78%
Eye irritation - 0.7344 73.44%
Skin irritation + 0.6941 69.41%
Skin corrosion - 0.8583 85.83%
Ames mutagenesis - 0.7600 76.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4053 40.53%
Micronuclear - 0.9900 99.00%
Hepatotoxicity - 0.8125 81.25%
skin sensitisation + 0.8266 82.66%
Respiratory toxicity - 0.6667 66.67%
Reproductive toxicity - 0.6164 61.64%
Mitochondrial toxicity - 0.6500 65.00%
Nephrotoxicity - 0.5781 57.81%
Acute Oral Toxicity (c) III 0.5709 57.09%
Estrogen receptor binding - 0.9470 94.70%
Androgen receptor binding - 0.7147 71.47%
Thyroid receptor binding - 0.6194 61.94%
Glucocorticoid receptor binding - 0.7507 75.07%
Aromatase binding - 0.9224 92.24%
PPAR gamma - 0.8256 82.56%
Honey bee toxicity - 0.9375 93.75%
Biodegradation + 0.5500 55.00%
Crustacea aquatic toxicity - 0.5800 58.00%
Fish aquatic toxicity + 0.9864 98.64%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 91.16% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.09% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 89.75% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 85.90% 97.25%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.39% 100.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.44% 95.56%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 84.11% 95.89%
CHEMBL3137262 O60341 LSD1/CoREST complex 83.87% 97.09%
CHEMBL1871 P10275 Androgen Receptor 83.21% 96.43%
CHEMBL5608 Q16288 NT-3 growth factor receptor 82.59% 95.89%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 81.54% 96.47%
CHEMBL3359 P21462 Formyl peptide receptor 1 81.20% 93.56%

Cross-Links

Top
PubChem 71608919
NPASS NPC269171